Goldman Sachs Group Inc Kamada LTD Put Options Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding KMDA
# of Institutions
39Shares Held
5.03MCall Options Held
14.3KPut Options Held
2K-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.3 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny808KShares$5.53 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA609KShares$4.16 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny448KShares$3.07 Million0.0% of portfolio
-
Y.D. More Investments LTD Ramat Gan, L3330KShares$2.26 Million0.19% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $306M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...